Recent clinical trials of immunotherapy in non-small-cell lung cancer

被引：7
|
作者：
Gkolfinopoulos, Stavros [1 ]
Mountzios, Giannis [2 ]
机构：
[1] BOC Oncol Ctr, Med Oncol Dept, CY-2006 Nicosia, Cyprus
[2] Henry Dunant Hosp Ctr, Med Oncol Dept 2, Athens 11526, Greece
来源：
IMMUNOTHERAPY | 2019年 / 11卷 / 06期
关键词：
atezolizumab; avelumab; checkpoint inhibitors; durvalumab; ipilimumab; nivolumab; non-small-cell lung cancer; pembrolizumab; DOCETAXEL; NIVOLUMAB; INTERLEUKIN-2; ATEZOLIZUMAB; BURDEN;
D O I：
10.2217/imt-2019-0021
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：461 / 466
页数：6
相关论文
共 50 条
  • [1] Current landscape of immunotherapy for the treatment of metastatic non-small-cell lung cancer
    Pabani, A.
    Butts, C. A.
    CURRENT ONCOLOGY, 2018, 25 : S94 - S102
  • [2] Immunotherapy combinations emerging in non-small-cell lung cancer
    Chao, Yvonne L.
    Pecot, Chad V.
    IMMUNOTHERAPY, 2018, 10 (08) : 627 - 629
  • [3] Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer
    Landi, Lorenza
    D'Inca, Federica
    Gelibter, Alain
    Chiari, Rita
    Grossi, Francesco
    Delmonte, Angelo
    Passaro, Antonio
    Signorelli, Diego
    Gelsomino, Francesco
    Galetta, Domenico
    Giannarelli, Diana
    Parra, Hector Soto
    Minuti, Gabriele
    Tiseo, Marcello
    Migliorino, Maria Rita
    Cognetti, Francesco
    Toschi, Luca
    Bidoli, Paolo
    Piantedosi, Francovito
    Calabro, Luana
    Cappuzzo, Federico
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01):
  • [4] Immunotherapy for non-small cell lung cancer
    Vafadar, Sam
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2019, 32 (09): : 37 - 42
  • [5] Predictive biomarkers for immunotherapy efficacy in non-small-cell lung cancer: current status and future perspectives
    C Guven, Deniz
    Sahin, Taha K.
    Dizdar, Omer
    Kilickap, Saadettin
    BIOMARKERS IN MEDICINE, 2020, 14 (14) : 1383 - 1392
  • [6] Nivolumab plus ipilimumab in non-small-cell lung cancer
    Reck, Martin
    Borghaei, Hossein
    O'Byrne, Kenneth J.
    FUTURE ONCOLOGY, 2019, 15 (19) : 2287 - 2302
  • [7] Adjuvant and Neoadjuvant Immunotherapy in Non - small Cell Lung Cancer
    Broderick, Stephen R.
    THORACIC SURGERY CLINICS, 2020, 30 (02) : 215 - +
  • [8] Immunotherapy revolutionises non-small-cell lung cancer therapy: Results, perspectives and new challenges
    Leprieur, Etienne Giroux
    Dumenil, Coraline
    Julie, Catherine
    Giraud, Violaine
    Dumoulin, Jennifer
    Labrune, Sylvie
    Chinet, Thierry
    EUROPEAN JOURNAL OF CANCER, 2017, 78 : 16 - 23
  • [9] Predictors for clinical benefit of immune checkpoint inhibitors in advanced non-small-cell lung cancer: a meta-analysis
    El-Osta, Hazem
    Jafri, Syed
    IMMUNOTHERAPY, 2019, 11 (03) : 189 - 199
  • [10] Current status of immunotherapy for non-small-cell lung cancer
    Imbimbo, Martina
    Lo Russo, Giuseppe
    Blackhall, Fiona
    TUMORI JOURNAL, 2016, 102 (04): : 337 - 351
12345